RAYNHAM, Mass., Oct. 3, 2018 /PRNewswire/ -- OMNIlife science, Inc. ("OMNI"), a privately-held, medical technology company targeting the $15 billion global hip and knee replacement device market, reported today that
Growth Capitalist (https://growthcapitalist.com/2018/10/omnilife-science-inc-achieves-milestone-with-omnibotics-active-spacer/)
RAYNHAM, Mass., Oct. 3, 2018 /PRNewswire/ -- OMNIlife science, Inc. ("OMNI"), a privately-held, medical technology company targeting the $15 billion global hip and knee replacement device market, reported today that